GEODE CAPITAL MANAGEMENT, LLC

Position in IMDX — Insight Molecular Diagnostics Inc.

CIK 1214717 BOSTON, MA

Position in IMDX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$859,533

-$872,749 QoQ

Shares Held

262,053

+13.5% QoQ

Ownership

0.812%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $15,360,896,443 across 43 Diagnostics & Research names. IMDX ranks #35 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	8,407,891	$4,132,730,662
2	DHR	Danaher Corp /De/	14,145,758	$2,682,035,716
3	IDXX	Idexx Laboratories Inc /De	2,660,999	$1,495,188,727
4	A	Agilent Technologies, Inc.	7,522,028	$857,360,751
5	WAT	Waters Corp /De/	2,646,458	$788,115,192
6	MTD	Mettler Toledo International Inc/	605,739	$763,958,026
7	IQV	Iqvia Holdings Inc.	4,463,052	$761,128,887
8	DGX	Quest Diagnostics Inc	3,086,308	$604,854,641

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$859,533	262,053	+13.5%	Shares	Defined	2026-05-15
2025-12-31	$1,732,282	230,971	+16.4%	Shares	Defined	2026-02-09
2025-09-30	$658,863	198,453	+25.9%	Shares	Defined	2025-11-12
2025-06-30	$475,891	157,580	-0.8%	Shares	Defined	2025-08-08
2025-03-31	$486,255	158,907	+15.9%	Shares	Defined	2025-05-13
2024-12-31	$326,223	137,069	+31.8%	Shares	Defined	2025-02-12
2024-09-30	$296,342	103,980	+12.2%	Shares	Defined	2024-11-12
2024-06-30	$273,438	92,691	+48.5%	Shares	Defined	2024-08-09
2024-03-31	$182,928	62,433	+1.5%	Shares	Defined	2024-05-13
2023-12-31	$153,705	61,482	0.0%	Shares	Defined	2024-02-13
2023-09-30	$191,823	61,482	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.